Eagle Harbor Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Eagle Harbor Asset Management's CORT Position: Q3 2026 in Review
Eagle Harbor Asset Management sold out of Corcept Therapeutics (CORT) in Q3 2026, closing a stake of 4,000 shares — an estimated $348K sold.
Eagle Harbor Asset Management first reported a position in CORT in Q2 2026 and held it in 1 quarter. The position peaked at $348K in Q2 2026. 503 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Eagle Harbor Asset Management reported no remaining Corcept Therapeutics position as of Q3 2026 after selling out during the quarter.
- Eagle Harbor Asset Management sold 4,000 Corcept Therapeutics shares in Q3 2026, an estimated $348K.
- Eagle Harbor Asset Management first reported a position in Corcept Therapeutics in Q2 2026 and held it in 1 quarter.
- Eagle Harbor Asset Management's Corcept Therapeutics position peaked at $348K in Q2 2026.
- 503 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Eagle Harbor Asset Management's 13F filing for Q3 2026, filed 21 Oct 2026.